MCID: MXD010
MIFTS: 14

Mixed Epithelial Stromal Tumour

Categories: Cancer diseases

Aliases & Classifications for Mixed Epithelial Stromal Tumour

MalaCards integrated aliases for Mixed Epithelial Stromal Tumour:

Name: Mixed Epithelial Stromal Tumour 12

Classifications:



External Ids:

Disease Ontology 12 DOID:5088
NCIt 47 C37265
UMLS 69 C1334602

Summaries for Mixed Epithelial Stromal Tumour

MalaCards based summary : Mixed Epithelial Stromal Tumour is related to cystic nephroma. The drugs Fentanyl and Pancreatic Polypeptide have been mentioned in the context of this disorder. Affiliated tissues include kidney, endothelial and ovary.

Wikipedia : 72 A cystic nephroma, also known as multilocular cystic nephroma, mixed epithelial stromal tumour (MEST)... more...

Related Diseases for Mixed Epithelial Stromal Tumour

Diseases related to Mixed Epithelial Stromal Tumour via text searches within MalaCards or GeneCards Suite gene sharing:

id Related Disease Score Top Affiliating Genes
1 cystic nephroma 11.2

Symptoms & Phenotypes for Mixed Epithelial Stromal Tumour

Drugs & Therapeutics for Mixed Epithelial Stromal Tumour

Drugs for Mixed Epithelial Stromal Tumour (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 50)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
2 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
3 Liver Extracts Phase 3,Phase 2
4 Adjuvants, Anesthesia Phase 3
5 Analgesics Phase 3
6 Analgesics, Opioid Phase 3
7 Anesthetics Phase 3
8 Anesthetics, General Phase 3
9 Anesthetics, Intravenous Phase 3
10 Central Nervous System Depressants Phase 3
11 Narcotics Phase 3
12 Peripheral Nervous System Agents Phase 3
13 Cola Nutraceutical Phase 3,Phase 2
14
Indinavir Approved Phase 2 150378-17-9 5362440
15
Ritonavir Approved, Investigational Phase 2 155213-67-5 392622
16
Progesterone Approved, Vet_approved Phase 2 57-83-0 5994
17
Amifostine Approved, Investigational Phase 1, Phase 2 20537-88-6 2141
18
Cyclophosphamide Approved, Investigational Phase 1, Phase 2 50-18-0, 6055-19-2 2907
19
Lenograstim Approved Phase 1, Phase 2 135968-09-1
20
Melphalan Approved Phase 1, Phase 2 148-82-3 4053 460612
21
Bevacizumab Approved, Investigational Phase 2 216974-75-3
22 Anti-HIV Agents Phase 2
23 Anti-Infective Agents Phase 2
24 Anti-Retroviral Agents Phase 2
25 Antiviral Agents Phase 2
26 Cytochrome P-450 CYP3A Inhibitors Phase 2
27 Cytochrome P-450 Enzyme Inhibitors Phase 2
28 HIV Protease Inhibitors Phase 2
29
protease inhibitors Phase 2
30 Hormone Antagonists Phase 2
31 Hormones Phase 2
32 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2
33 Progestins Phase 2
34 Alkylating Agents Phase 1, Phase 2
35 Antirheumatic Agents Phase 1, Phase 2
36 Immunosuppressive Agents Phase 1, Phase 2
37 Protective Agents Phase 1, Phase 2
38 Radiation-Protective Agents Phase 1, Phase 2
39 Antibodies Phase 2,Phase 1
40 Antibodies, Monoclonal Phase 2,Phase 1
41 Immunoglobulins Phase 2,Phase 1
42 Angiogenesis Inhibitors Phase 2
43 Angiogenesis Modulating Agents Phase 2
44 Endothelial Growth Factors Phase 2
45 Mitogens Phase 2
46
Vorinostat Approved, Investigational Phase 1 149647-78-9 5311
47 Immunotoxins Phase 1
48 Histone Deacetylase Inhibitors Phase 1
49 Vaccines Phase 1
50
Formaldehyde Approved, Vet_approved 50-00-0 712

Interventional clinical trials:


id Name Status NCT ID Phase Drugs
1 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
2 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2 indinavir sulfate;ritonavir
3 Breast Cancer - Anti-Progestin Prevention Study 1 Unknown status NCT02408770 Phase 2 ulipristal acetate
4 Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect Completed NCT00003425 Phase 1, Phase 2 amifostine trihydrate;cyclophosphamide;melphalan
5 Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary Active, not recruiting NCT00748657 Phase 2
6 Immunotoxin Therapy in Treating Patients With Advanced Cancer Completed NCT00006981 Phase 1
7 Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer Completed NCT00045006 Phase 1 vorinostat
8 A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen Completed NCT00623831 Phase 1
9 Collecting Tumor Samples From Patients With Gynecological Tumors Completed NCT00897442

Search NIH Clinical Center for Mixed Epithelial Stromal Tumour

Genetic Tests for Mixed Epithelial Stromal Tumour

Anatomical Context for Mixed Epithelial Stromal Tumour

MalaCards organs/tissues related to Mixed Epithelial Stromal Tumour:

39
Kidney, Endothelial, Ovary, Liver, Brain, Breast

Publications for Mixed Epithelial Stromal Tumour

Articles related to Mixed Epithelial Stromal Tumour:

id Title Authors Year
1
Exophytic benign mixed epithelial stromal tumour of the kidney: case report of a rare tumour entity. ( 20193076 )
2010
2
Aggressive mixed epithelial-stromal tumour of the kidney treated with chemotherapy and radiotherapy. ( 15581546 )
2004

Variations for Mixed Epithelial Stromal Tumour

Expression for Mixed Epithelial Stromal Tumour

Search GEO for disease gene expression data for Mixed Epithelial Stromal Tumour.

Pathways for Mixed Epithelial Stromal Tumour

GO Terms for Mixed Epithelial Stromal Tumour

Sources for Mixed Epithelial Stromal Tumour

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....